Oxidative transformations of environmental pharmaceuticals by Cl2, ClO2, O3, and Fe(VI): Kinetics assessment

被引:170
作者
Sharma, Virender K. [1 ]
机构
[1] Florida Inst Technol, Dept Chem, Melbourne, FL 32901 USA
关键词
Chlorination; Ozonation; Chlorine dioxide; Ferrate; Drugs; Antibiotics;
D O I
10.1016/j.chemosphere.2008.08.033
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Several pharmaceuticals have been detected globally in surface water and drinking water. which indicate their insufficient removal from water and wastewater using conventional treatment methods. This paper reviews the kinetics of oxidative transformations of pharmaceuticals (antibiotics, lipid regulators, antipyretics, anticonvulsants, and beta-blockers) by Cl-2, ClO2, O-3, and ferrate(VI) ((FeO42-)-O-VI, Fe(VI)) under treatment conditions. in the chlorination of sulfonamide antibiotics, HOCl is the major reactive Cl-2 species whereas in the oxidation by Fe(VI), HFeO4- is the dominant reactive species. Both oxidation processes can oxidize sulfonamides in seconds at a neutral pH (t(1/2) <= 220 s; 1 mg L-1 HOCl or K2FeO4). The reactivity of O-3 with pharmaceuticals is generally higher than that of HOCl (k(app.pH) (7) (O-3) = 1-10(7) M-1 s(-1); k(app.pH) (7) (HOCl) = 10(-2)-10(5) M-1 s(-1)). Ozone selectively oxidizes pharmaceuticals and reacts mainly with activated aromatic systems and non-protonated amines. Oxidative transformation of most pharmaceuticals by O-3 occurs in seconds (t(1/2) <= 100 s; 1 mg L-1 O-3) while half-lives for oxidations by HOCl differ by at least two orders of magnitude. Ozone appears to be efficient in oxidizing pharmaceuticals in aquatic environments. The limited work on Fe(VI) shows that it can also potentially transform pharmaceuticals in treatment processes. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1379 / 1386
页数:8
相关论文
共 58 条
[1]   Removal of antibiotics from surface and distilled water in conventional water treatment processes [J].
Adams, C ;
Wang, Y ;
Loftin, K ;
Meyer, M .
JOURNAL OF ENVIRONMENTAL ENGINEERING-ASCE, 2002, 128 (03) :253-260
[2]   Screening analysis of human pharmaceutical compounds in US surface waters [J].
Anderson, PD ;
D'Aco, VJ ;
Shanahan, P ;
Chapra, SC ;
Buzby, ME ;
Cunningham, VL ;
Duplessie, BM ;
Hayes, EP ;
Mastrocco, FJ ;
Parke, NJ ;
Rader, JC ;
Samuelian, JH ;
Schwab, BW .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2004, 38 (03) :838-849
[3]   Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment [J].
Andreozzi, R ;
Marotta, R ;
Paxeus, N .
CHEMOSPHERE, 2003, 50 (10) :1319-1330
[4]   Antibiotic removal from wastewaters: The ozonation of amoxicillin [J].
Andreozzi, R ;
Canterino, M ;
Marotta, R ;
Paxeus, N .
JOURNAL OF HAZARDOUS MATERIALS, 2005, 122 (03) :243-250
[5]  
[Anonymous], 1998, CHLORINE DIOXIDE HDB
[6]   Comparison of the occurrence of antibiotics in four full-scale wastewater treatment plants with varying designs and operations [J].
Batt, Angela L. ;
Kim, Sungpyo ;
Aga, Diana S. .
CHEMOSPHERE, 2007, 68 (03) :428-435
[7]   Ozonation of reverse osmosis concentrate: Kinetics and efficiency of beta blocker oxidation [J].
Benner, Jessica ;
Salhi, Elisabeth ;
Ternes, Thomas ;
von Gunten, Urs .
WATER RESEARCH, 2008, 42 (12) :3003-3012
[8]   Photochemical fate of sulfa drugs in the aquatic environment: Sulfa drugs containing five-membered heterocyclic groups [J].
Boreen, AL ;
Arnold, WA ;
McNeill, K .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2004, 38 (14) :3933-3940
[9]  
CARTISER S, 2007, CHEMOSPHERE, V67, P604
[10]   Oxidation of sulfonamides, macrolides, and carbadox with free chlorine and monochloramine [J].
Chamberlain, E. ;
Adams, C. .
WATER RESEARCH, 2006, 40 (13) :2517-2526